PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Frequently asked questions
What sector does PolyNovo Limited (CALZF) operate in?
PolyNovo Limited belongs to the Healthcare sector and operates in the Medical Devices industry.
What is PolyNovo Limited (CALZF) current stock price?
As of the latest data, PolyNovo Limited stock price is $0.55, with a previous close of $0.62. PolyNovo Limited lost -$0.07 in the last trading session, representing a -10.65% loss.
What is PolyNovo Limited (CALZF) current market capitalization?
PolyNovo Limited market cap is approximately 382.73 million.
What is PolyNovo Limited (CALZF) Earnings Per Share (EPS)?
The trailing EPS is $0.01.
What is PolyNovo Limited (CALZF) Price-to-Earnings (P/E) ratio?
PolyNovo Limited current P/E ratio is 55.4.
What is PolyNovo Limited (CALZF) EBITDA?
PolyNovo Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 6.50 million.
Does PolyNovo Limited (CALZF) pay dividends?
No. PolyNovo Limited does not pay a dividend.
What is PolyNovo Limited (CALZF) beta (volatility) score?
PolyNovo Limited has a beta of 1.345, suggesting it is more volatile than the market.
